New drug duo aims to stop aggressive kidney Cancer's comeback
NCT ID NCT07488533
Summary
This study is testing whether a combination of two drugs can help prevent a less common type of kidney cancer from returning after surgery. The treatment involves an IV medication and a daily pill given for up to one year to 40 patients at high risk of their cancer coming back. The goal is to see if this approach helps patients stay cancer-free longer after their operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-CLEAR CELL RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.